25 Feb 2018 | 1:48 PM
 

Glenmark Pharmaceuticals Ltd. Share Price Live (BSE)
0

BSE Code: 532296 | NSE Symbol: GLENMARK
533.80
9.40
(1.80 %)
23 Feb 2018 | 03:59 PM
Change company
  • Open (Rs)
    521.15
  • Prev. close (Rs.)
    524.40
  • High (Rs.)
    536.50
  • Low (Rs.)
    521.15
  • 52W H (Rs.)
    944.10
  • 52W L (Rs.)
    517.40
  • Volume
    52204
  • MCap (Rs in Cr.)
    15,062.13
538.5
12.25
(2.33 %)
  • Open (Rs)
    528.45
  • High (Rs)
    539.00
  • Low (Rs)
    527.60
  • Prev. close(Rs)
    526.25
  • Contracts Tra.
    17,25,300
  • Turnover (Cr.)
    92
  • Open Interest
    67,01,400
  • Open Int. chg
    66,88,100.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
39.30
Operating Margin (%)
22.17
Gross Profit Margin (%)
19.29
Net Profit Margin (%)
12.07
Total Debt/Equity
1.05
Dividend payout Ratio (Net Profit)
0.00
Earning Retention Ratio
100.00

News

22 Feb 2018 - 09:19:00-Glenmark Pharmaceuticals a global pharmaceutical company has said that it has entered into an exclus...
09 Feb 2018 - 11:27:00-Shares of Glenmark Pharmaceuticals plunged over 9 per cent on the Bombay Stock Exchange after the dr...
08 Feb 2018 - 19:26:00-The company reported standalone net profit of Rs 194...
25 Jan 2018 - 10:06:00-Glenmark Pharmaceuticals a global pharmaceutical company has said that it has presented preliminary ...

Announcements

22-Feb-2018
Glenmark Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release
22-Feb-2018
Glenmark Pharma - Press Release
19-Feb-2018
Glenmark Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release
19-Feb-2018
Glenmark Pharma - Press Release
19-Feb-2018
Glenmark Pharma presents new data on GBR 830

Religare Research

23 Feb 2018 | 06:00 PM
The power transmission sector outlook remains bright with huge energy demand in India, increasing in...
23 Feb 2018 | 06:00 PM
The benchmark index, Nifty traded volatile and consolidated in a range as participants preferred to ...
23 Feb 2018 | 03:14 PM
Nifty futures has rolled around 62% vs 66% with respect to last month, and the open interest for the...
23 Feb 2018 | 12:40 PM
Highlights: Prospects of rains in parts of MP, Maharashtra, North-West and North India during w...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
10,00,000 115.06 73.57 0.91
10,00,000 115.06 66.80 0.91
10,00,000 115.06 205.52 0.91
10,00,000 115.06 213.32 0.92
10,00,000 115.06 77.15 0.92

Shareholding Pattern

       
Promotors46.54%
Mutual Funds/UTI3.20%
FI/Banks2.84%
Insurance2.84%
FII31.03%
Government0.00%
Others4.76%

Peer Group

Company Intraday Graph
 Abbott India Ltd.
5,788.40(0.72)
3280
 Sanofi India Ltd.
4,832.00(0.14)
3325
 Piramal Enterprises Ltd.
2,622.05(1.31)
3356
 GlaxoSmithKline Pharmaceuticals Ltd.
2,397.70(0.09)
3317

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Glenmark Pharmaceuticals Ltd.-97.90-60.00-67.60
NIFTY(S&P CNX)-592.65142.30638.55
BSE SENSEX-1,997.83554.072,574.14
BSE 500-979.4167.751,053.83

Corporate Details

Key Personal
B E Saldanha
Non Executive Director
Bernard Munos
Non Exe. & Ind. Director
Brian W Tempest
Non Exe. & Ind. Director
Key Address
Registered Office
B/2 Mahalaxmi Chambers 22 Bhulabhai Desai Road,Mumbai,Maharashtra

Tel:022-40189999 40189879, Fax:022-40189986

csr@glenmarkpharma.com
http://www.glenmarkpharma.com
Registrar Office
Karvy Computershare Private Ltd.
Add. :Karvy Selenium Tower B Plot No. 31-32 Gachibowli Financial District Nanakramguda